Gürkan Çelebi
- Speech and Hearing top 5%
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 3
- Nephrology top 10%
-
- Liver Disease Diagnosis and Treatment 8
- Adipokines, Inflammation, and Metabolic Diseases 4
-
- Lipid metabolism and disorders 3
- Cardiovascular Disease and Adiposity 2
-
- Helicobacter pylori-related gastroenterology studies 3
- Total Knee Arthroplasty Outcomes 3
-
- Biomarkers in Disease Mechanisms 2
- Co-authors
- Halil GençTeoman DoğruCemal Nuri ErçinMurat PehlivanErdim SertoğluAlper SönmezSerkan TapanMuammer Kara
- Journals
- Clinical Biochemistry (2 papers)European Journal of Gastroenterology & Hepatology (2 papers)Journal of Hypertension (1 paper)
- Partner nations
- TürkiyeUnited StatesRwanda
In The Last Decade
Gürkan Çelebi
35 papers receiving 580 citations
Peers
Comparison fields: 5 of 111
- Complementary and Manual Therapy 63
- Speech and Hearing 70
- Endocrinology, Diabetes and Metabolism 103
- Nephrology 43
- Epidemiology 180
Countries citing papers authored by Gürkan Çelebi
This map shows the geographic impact of Gürkan Çelebi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gürkan Çelebi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gürkan Çelebi more than expected).
Fields of papers citing papers by Gürkan Çelebi
This network shows the impact of papers produced by Gürkan Çelebi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gürkan Çelebi. The network helps show where Gürkan Çelebi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gürkan Çelebi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2021 | 4 | |
| 3 | 2020 | 10 | |
| 4 | Plasma pentraxin-3 is associated with endothelial dysfunction in non-alcoholic fatty liver disease. | 2016 | 19 |
| 5 | 2016 | 8 | |
| 6 | 2015 | 33 | |
| 7 | 2015 | 25 | |
| 8 | 2014 | 54 | |
| 9 | 2013 | 5 | |
| 10 | 2011 | 14 | |
| 11 | 2010 | 79 | |
| 12 | 2010 | 0 | |
| 13 | 2010 | 29 | |
| 14 | 2009 | 1 | |
| 15 | 2009 | 16 | |
| 16 | 2006 | 16 | |
| 17 | 2002 | 68 | |
| 18 | 1997 | 3 | |
| 19 | 1997 | 13 | |
| 20 | 1991 | 0 |
About Gürkan Çelebi
Gürkan Çelebi is a scholar working on Complementary and Manual Therapy, Epidemiology and Cardiology and Cardiovascular Medicine, having authored 37 papers that have together received 599 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (8 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers), Lipid metabolism and disorders (3 papers), Helicobacter pylori-related gastroenterology studies (3 papers), Total Knee Arthroplasty Outcomes (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Cardiovascular Disease and Adiposity (2 papers) and Biomarkers in Disease Mechanisms (2 papers). The work is most often cited by research in Complementary and Manual Therapy (63 citations), Speech and Hearing (70 citations) and Endocrinology, Diabetes and Metabolism (103 citations). Gürkan Çelebi has collaborated with scholars based in Türkiye, United States and Rwanda. Frequent co-authors include Halil Genç, Teoman Doğru, Cemal Nuri Erçin, Murat Pehlivan, Erdim Sertoğlu, Alper Sönmez, Serkan Tapan, Muammer Kara, Cumhur Erteki̇n and Hüseyin Kayadibi. Their work appears in journals such as Clinical Biochemistry, European Journal of Gastroenterology & Hepatology, Journal of Hypertension, International Orthopaedics and Clinical and investigative medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.